Long pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #38,001 to #38,050.
- (hist) Chou-Fasman method [5,401 bytes]
- (hist) External carotid artery [5,401 bytes]
- (hist) Familial amyloidosis physical examination [5,400 bytes]
- (hist) ADAMTS17 [5,400 bytes]
- (hist) AK3L1 [5,400 bytes]
- (hist) Ileus risk factors [5,400 bytes]
- (hist) BBCH-scale (leafy vegetables not forming heads) [5,400 bytes]
- (hist) Eukaryotic transcription [5,400 bytes]
- (hist) Listeriolysin O [5,400 bytes]
- (hist) UGT2B17 [5,399 bytes]
- (hist) Cerebral palsy natural history, complications and prognosis [5,399 bytes]
- (hist) Diphyllobothriasis pathophysiology [5,399 bytes]
- (hist) Erectile dysfunction pathophysiology [5,399 bytes]
- (hist) Aortic stenosis surgery recovery [5,399 bytes]
- (hist) Cardamom [5,399 bytes]
- (hist) Substance D [5,399 bytes]
- (hist) Medical procedure [5,399 bytes]
- (hist) Morphine Sulfate Injection (patient information) [5,399 bytes]
- (hist) WBR0508 [5,398 bytes]
- (hist) Cervical cancer surgery [5,398 bytes]
- (hist) Congenital abnormality [5,398 bytes]
- (hist) ATF7 [5,398 bytes]
- (hist) Stereocilia (inner ear) [5,398 bytes]
- (hist) Gillenia [5,398 bytes]
- (hist) Fuchsine [5,398 bytes]
- (hist) Freund's adjuvant [5,398 bytes]
- (hist) Fragile X syndrome overview [5,397 bytes]
- (hist) TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis [5,397 bytes]
- (hist) Trisomy 22 [5,397 bytes]
- (hist) WHSC1L1 [5,396 bytes]
- (hist) Cholangitis risk factors [5,396 bytes]
- (hist) PPHLN1 [5,396 bytes]
- (hist) Piped link [5,396 bytes]
- (hist) Membranous glomerulonephritis diagnostic study of choice [5,395 bytes]
- (hist) GRIK3 [5,395 bytes]
- (hist) Diabetic foot historical perspective [5,395 bytes]
- (hist) Cardiac tamponade physical examination [5,395 bytes]
- (hist) Bowel obstruction (patient information) [5,395 bytes]
- (hist) RBBP6 [5,395 bytes]
- (hist) The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Diabetic Patients Suggest Revisions to the CLASS IIa Guidelines [5,395 bytes]
- (hist) Social isolation [5,395 bytes]
- (hist) Incapacitating agent [5,395 bytes]
- (hist) CHCHD2 [5,394 bytes]
- (hist) NLRP4 [5,394 bytes]
- (hist) Cefuroxime axetil microbiology [5,394 bytes]
- (hist) Whipworm infection epidemiology and demographics [5,394 bytes]
- (hist) TNP1 [5,394 bytes]
- (hist) The Living Guidelines: Pharmacological rate control during atrial fibrillation Polling Results for CLASS III Guidelines [5,393 bytes]
- (hist) Pedant [5,393 bytes]
- (hist) FRAT1 [5,393 bytes]